Preoperative ESR1 mRNA therapy in cases with an advanced stage of ER-negative or TNBC-type breast cancer may result in an obvious tumor response coupled with stimulated immune-competent cells in the neighboring tissues. The gene discussed is ESR1; the disease is breast carcinoma.